Literature DB >> 2843525

Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16.

A K Jaiswal1, O W McBride, M Adesnik, D W Nebert.   

Abstract

NAD(P)H:menadione oxidoreductase (NMOR1) is a flavoprotein that catalyzes the two-electron reduction of various redox dyes and quinones. It has been proposed that this enzyme may have a protective effect against cancer caused by quinones and their metabolic precursors. We show that tetrachlorodibenzo-p-dioxin (TCDD) treatment of the human hepatoblastoma cell line Hep-G2 produces a 5-fold induction of NMOR activity. Several overlapping human NMOR1 cDNAs were isolated from a human liver lambda gt 11 expression library, and their composite sequence corresponds to an mRNA of 2448 nucleotides containing a continuous open reading frame encoding a protein of 274 residues (molecular weight, 30,880). The corresponding human NMOR1 mRNA has an unusually long 3'-untranslated region (1679 base pairs) with four potential polyadenylation signals (I-IV) at positions 986, 1460, 1838, and 2419 and a single copy of human Alu repetitive sequence between polyadenylation sites II and III. Southern blot analysis of human genomic DNA suggests the presence of a single NMOR1 gene approximately 10 kilobases (KB) in length. The use of three of the aforementioned polyadenylation signals is likely to account for the three different species (2.7, 1.7, and 1.2 kb) of mRNA hybridizing to NMOR1 cDNA in Hep-G2 cells. Indeed several partial cDNA clones were isolated that corresponded to the mRNA derived by use of the proximal polyadenylation signal. Interestingly, the longest (2.7 kb) mRNA species was induced severalfold by TCDD, whereas the other two mRNAs (1.7 and 1.2 kb) were induced to a much lesser extent by TCDD treatment. The human NMOR1 cDNA and protein are 83 and 85% similar to rat liver cytosolic NMOR1 cDNA and protein, respectively. Southern analysis of DNA from 54 human x mouse and 39 human x hamster somatic cell hybrids shows that the NMOR1 gene resides on human chromosome 16.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Enzymology of bioreductive drug activation.

Authors:  D Ross; H D Beall; D Siegel; R D Traver; D L Gustafson
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups.

Authors:  A T Dinkova-Kostova; M A Massiah; R E Bozak; R J Hicks; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.

Authors:  Rui Ding; Shilei Lin; Daojun Chen
Journal:  Int J Colorectal Dis       Date:  2012-01-04       Impact factor: 2.571

4.  Subunit functional studies of NAD(P)H:quinone oxidoreductase with a heterodimer approach.

Authors:  K Cui; A Y Lu; C S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

5.  Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

Authors:  P J O'Dwyer; C E Szarka; K S Yao; T C Halbherr; G R Pfeiffer; F Green; J M Gallo; J Brennan; H Frucht; E B Goosenberg; T C Hamilton; S Litwin; A M Balshem; P F Engstrom; M L Clapper
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

6.  Marked increases in hepatic NAD(P)H:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 deletion.

Authors:  D D Petersen; F J Gonzalez; V Rapic; C A Kozak; J Y Lee; J E Jones; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats.

Authors:  Sudha R Kondraganti; Weiwu Jiang; Anil K Jaiswal; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2008-01-17       Impact factor: 4.849

8.  NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

Authors:  Seema Singh; Muhammad Zahid; Muhammad Saeed; Nilesh W Gaikwad; Jane L Meza; Ercole L Cavalieri; Eleanor G Rogan; Dhrubajyoti Chakravarti
Journal:  J Steroid Biochem Mol Biol       Date:  2009-07-21       Impact factor: 4.292

9.  The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.

Authors:  S S Pan; S A Akman; G L Forrest; C Hipsher; R Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Introducing the "TCDD-inducible AhR-Nrf2 gene battery".

Authors:  Ronnie L Yeager; Scott A Reisman; Lauren M Aleksunes; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-05-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.